STAY INFORMED. VISIT NHIA.ORG/COVID19 FOR INFORMATION AND RESOURCES ABOUT CORONAVIRUS DISEASE (COVID-19).

NHIF Benchmarking Program

Be part of NHIF’s benchmarking program to collect industry-wide, standardized data to establish a national reference point for performance and clinical metrics.

 

NHIA Bamlanivimab pilot program

Learn more about NHIA’s work to increase access to bamlanivimab for COVID-19 in high-risk, eligible individuals residing or working in long-term care facilities, including assisted living facilities.

ADVOCACY INITIATIVES

Learn more about NHIA’s advocacy priorities and how you can get involved.​

Latest News

May 6, 2021
NHIA Releases Statement On CMS’ Medicare Payment Rate Increase for Monoclonal Antibody Treatments
NHIA has issued a statement on the decision made today by the Centers for Medicare & Medicaid Services (CMS) to increase the Medicare payment rate for administering monoclonal antibodies.

May 6, 2021
NHIA Named Recipient of ASAE 2021 Gold Circle Award for INFUSION Magazine
The National Home Infusion Association (NHIA) is pleased to be the recipient of an American Society of Association Executives (ASAE) 2021 Gold Circle Award for the association’s bi-monthly INFUSION print magazine, which underwent a redesign in 2019.

April 22, 2021
National Home Infusion Association Announces 2022 Annual Conference to be held in Nashville
NHIA has announced that their 2022 Annual Conference will be held on-site in Nashville, Tennessee, March 12-16, 2022. The conference is the premier event for the home and specialty infusion industry and will be held at the Gaylord Opryland Resort & Convention Center, just minutes away from downtown Nashville.

April 21, 2021
National Home Infusion Foundation announces recipient of 2021 Outstanding Abstract Achievement Award
NHIF is proud to announce that the recipient of the 2021 Outstanding Abstract Achievement Award (OAAA) is Christina Ritchey, MS, RD, LD, CNSC. The OAAA is awarded to an individual that presents a poster during the National Home Infusion Association’s (NHIA) Annual Conference on a relevant home and specialty infusion topic. 

April 19, 2021
NHIF announces 2021 Lynn Giglione Women in Leadership Award recipient
NHIF  is proud to announce that Cindy Sumrall, RN, BSN, CRNI, IgCN is the recipient of the 2021 Lynn Giglione Women in Leadership Award. The Lynn Giglione Women in Leadership Award is given each year to recognize and honor trail-blazing and accomplished women leaders who have distinguished themselves within their organizations and among their industry peers.

April 19, 2021
NHIA Announces Recipient of 2021 Gene Graves Lifetime Achievement Award
NHIA is proud to announce that Varner R. Richards, PharmD is the recipient of the 2021 Gene Graves Lifetime Achievement Award. The Gene Graves Lifetime Achievement Award is the highest honor that NHIA bestows on a member of the home and specialty infusion community.

April 16, 2021
NHIA Submits Comments on Proposed EN and PN LCDs
On April 10, NHIA submitted written comments to the Durable Medical Equipment Medicare Administrative Contractors (DME MACs) on proposed local coverage determinations (LCDs) for enteral nutrition (DL38955) and parenteral nutrition (DL38953). The association also provided oral comments in a public meeting held by the DME MACs in March.
Read NHIA’s EN comments | Read NHIA’s PN comments

April 12, 2021
NHIA Releases White Paper on Policy Impacts on Medicare Beneficiary Access to Part B DMEPOS Home Infusion Therapy
The Part B Durable Medical Equipment and Prosthetics/ Orthotics and Supplies (DMEPOS) benefit serves an important need in the Medicare program by creating home infusion
access for a small number of highly vulnerable
beneficiaries who rely on continuous infusions of lifesaving medications.

April 5, 2021
NHIA Statement on Commercial Payer Coverage for Home Infusion of COVID-19 Monoclonal Antibodies
The National Home Infusion Association is concerned that some commercial insurance plans have not yet implemented coverage policies for home administration of COVID-19 monoclonal antibodies. For decades, patients with employer-based insurance plans have benefited from a robust, pharmacy-led home infusion model that ensures equitable access to infused therapies.

March 30, 2021
NHIA Takes Virtual Event to Next Level
After cancelling its annual conference last year, the National Home Infusion Association is back with a virtual event to “reconnect everyone,” says COO Jennifer Charron. With virtual events increasing in frequency due to the pandemic, the association hired a production crew to produce the event and take it to the next level, she says.

February 9, 2021
NHIA Sends Letter to Biden Administration on Home & Specialty Infusion
Today, NHIA sent a letter to key members of the Biden administration, urging them to prioritize home-based care as the nation continues its recovery from COVID-19. In the letter, NHIA applauded the administration’s focus on health care and combatting the coronavirus, and outlined four policy recommendations related to the home and specialty infusion industry.

February 3, 2021
NHIA Offers Suggestions on MOU implementation to FDA, NABP On February 1, NHIA sent a letter to the U.S. Food and Drug Administration (FDA) and the National Association of Boards of Pharmacy (NABP) offering suggestions to improve implementation of the Memorandum of Understanding (MOU) between the 2 entities. Specifically, NHIA encouraged: state boards of pharmacy to act expeditiously in determining whether or not they will enter into the MOU and make special efforts to communicate their intentions; states to give pharmacies at least 120 days’ notice; state boards of pharmacy and NABP to conduct regular stakeholder outreach; and NABP to create a compounding stakeholder information resource where information can be consolidated regarding the status of each state’s participation.

January 30, 2021
NHIA Submits Comments on Proposed Change of External Infusion Pump LCD
The National Home Infusion Association (NHIA) submitted comments on the proposed change of the External Infusion Pump LCD, adding coverage for chronic inflammatory demyelinating polyneuropathy (CIDP) as an approved indication for Hizentra. 

January 15, 2021
NHIA Announces 16 Home Infusion Fellows in Program’s Inaugural Year
The National Home Infusion Association (NHIA) is pleased to announce the inaugural Fellow Program (FNHIA) cohort, made up of highly accomplished home and specialty infusion professionals. The program is administered and funded by the National Home Infusion Foundation (NHIF), thanks to a generous contribution from Integrated Medical Systems, Inc. (IMS), the 2021 sponsor of the NHIA Fellow Program.

January 13, 2021
NHIA Submits Comments on Termination of FDA’s Unapproved Drugs Initiative
NHIA has submitted comments to the Department of Health and Human Services (HHS) on the notice, “Termination of the Food and Drug Administration’s (FDA) Unapproved Drugs Initiative; Request for Information Regarding Drugs Potentially Generally Recognized as Safe and Effective”, which outlines the FDA’s decision to terminate the Unapproved Drugs Initiative (UDI).

January 12, 2021
Improving Access to COVID Vaccines for Homebound, Rural, and Vulnerable Populations
The National Home Infusion Association (NHIA) and National Association for Home Care and Hospice (NAHC) are urging the Department of Health and Human Services (HHS) and state health departments to ensure home infusion pharmacies are able to access vaccines and supply them either directly, or in collaboration with home health providers.

January 6, 2021
NHIA announces keynote for first-ever Global Congress on Home Infusion Therapy
The National Home Infusion Association (NHIA) will be hosting the first-ever Global Congress on Home Infusion Therapy (GCHIT) on April 19, 2021, and Daniel Kraft, MD, a health technology expert, will serve as the event’s keynote speaker. Held as a pre-conference to NHIA’s 2021 Annual Conference, the GCHIT offers an opportunity for home infusion clinicians and providers from across the world to share experiences, ideas, accomplishments, and challenges associated with the delivery of infused medications in the home setting.

December 22, 2020
NHIA Submits Comments on CMS’ DMEPOS Proposed Rule
NHIA has submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the proposed rule “Medicare Program; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Policy Issues and Level II of the Healthcare Common Procedure Coding System (HCPCS)”, published on November 4. The rule proposed new criteria for the definition of when an ambulatory infusion pump is “appropriate for use in the home”. NHIA members are encouraged to submit their own comments to CMS on this proposed rule. All comments are due by 5 p.m. on January 4, 2021. 

We Need Your Support

NHIA is dedicating extra resources to pursue legislation to allow home infusion providers to serve Medicare beneficiaries during the public health emergency related to COVID-19.